Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended adjusting the marketing authorisation of Bavarian…
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended adjusting the marketing authorisation of Bavarian…
The US Food and Drug Administration (FDA) has granted ConSynance Therapeutics a rare paediatric disease designation for its oral therapy…
A day after announcing a $400m convertible bond offering, Telix Pharmaceuticals has had a new drug application (NDA) accepted by…
Not long after pulling a last-minute plug on a $232m initial public offering (IPO) on Nasdaq, Telix Pharmaceuticals has raised…
Almirall has reported a 6.7% increase in total net sales for the first half of 2024, with the company’s European…
Since last year, NVIDIA has generated shockwaves in many industries – with healthcare being no exception. Boasting a market cap…
Boehringer Ingelheim will sell an unbranded version AbbVie’s reference drug at a 92% discount to gain traction in the Humira…
Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building that…
Six months after winning fast track status for multiple sclerosis, Kyverna Therapeutics’ KYV-101 has secured another US Food and Drug…
A joint report by United Nations (UN) agencies has revealed that global immunisation coverage has stalled, remaining largely unchanged from…